FDA plans fast-track development and marketing program for medical devices that treat opioid addiction

By Stewart Eisenhart, Emergo Group

Medical device regulators at the US Food and Drug Administration have initiated a new campaign to support development and commercialization of novel devices aimed at pain treatment and opioid addiction.

Get the full story here at the Emergo Group’s blog.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

The post FDA plans fast-track development and marketing program for medical devices that treat opioid addiction appeared first on MassDevice.

from MassDevice https://ift.tt/2J7zikq